A detailed history of Sunburst Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sunburst Financial Group, LLC holds 2,259 shares of ABBV stock, worth $402,124. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,259
Previous 2,459 8.13%
Holding current value
$402,124
Previous $421,000 5.94%
% of portfolio
0.12%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$163.84 - $199.33 $32,768 - $39,866
-200 Reduced 8.13%
2,259 $446,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $81,109 - $94,718
524 Added 27.08%
2,459 $421,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $19,018 - $21,669
119 Added 6.55%
1,935 $352,000
Q4 2023

Jan 08, 2024

BUY
$137.6 - $154.97 $1,100 - $1,239
8 Added 0.44%
1,816 $281,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $534 - $618
4 Added 0.22%
1,808 $269,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $8,480 - $10,553
-64 Reduced 3.43%
1,804 $243,000
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $32,392 - $37,304
-224 Reduced 10.71%
1,868 $297,000
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $12,309 - $14,762
89 Added 4.44%
2,092 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $1,476 - $1,693
11 Added 0.55%
2,003 $269,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $38,808 - $49,338
-282 Reduced 12.4%
1,992 $305,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $26,923 - $33,405
204 Added 9.86%
2,274 $369,000
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $966 - $1,223
9 Added 0.44%
2,070 $280,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $4,149 - $4,710
39 Added 1.93%
2,061 $222,000
Q2 2021

Jul 23, 2021

SELL
$105.21 - $117.21 $8,837 - $9,845
-84 Reduced 3.99%
2,022 $228,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $215,443 - $237,177
2,106 New
2,106 $228,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sunburst Financial Group, LLC Portfolio

Follow Sunburst Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunburst Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunburst Financial Group, LLC with notifications on news.